Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological Cancers
Immunomodulatory drugs (IMiDs) are widely utilized therapies in multiple hematological cancers; however, their clinical application is frequently constrained by drug resistance. Here, though screening of diverse cereblon (CRBN) binders, comprehensive structure–activity relationships (SAR) analyses a...
Saved in:
| Hovedforfatter: | |
|---|---|
| Andre forfattere: | , , , , , , , , , , , , , , , , , , , , |
| Udgivet: |
2025
|
| Fag: | |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|